OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
4.070
+0.510 (14.33%)
At close: May 21, 2026, 4:00 PM EDT
4.000
-0.070 (-1.72%)
After-hours: May 21, 2026, 6:08 PM EDT

OnKure Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
192.1159.05110.7629.8819.93124.66
Short-Term Investments
----81.2523.01
Cash & Short-Term Investments
192.1159.05110.7629.88101.17147.67
Cash Growth
98.74%-46.69%270.74%-70.47%-31.49%175.44%
Other Current Assets
5.381.792.243.895.186.06
Total Current Assets
197.4860.8411333.77106.35153.73
Net Property, Plant & Equipment
0.811.011.81.911.750.21
Other Long-Term Assets
0.410.270.110.060.080.08
Total Assets
198.6962.12114.9135.73108.18154.02
Accounts Payable
11.021.432.973.421.892.02
Accrued Expenses
2.93.947.033.664.834.18
Current Portion of Leases
0.410.550.540.210.4-
Total Current Liabilities
14.335.9210.537.297.126.2
Long-Term Leases
--0.550.471.060.17
Other Long-Term Liabilities
0.010.01--0.030.44
Total Long-Term Liabilities
0.010.010.550.471.090.61
Total Liabilities
14.345.9311.087.758.216.81
Preferred Stock
---129.83--
Common Stock
000-00
Additional Paid-in Capital
413.75270.42258.550.21236.69231.9
Accumulated Other Comprehensive Income
-----0.040.03
Retained Earnings
-229.4-214.24-154.72-102.05-136.68-84.73
Shareholders' Equity
184.3556.18103.83-101.8499.97147.21
Total Liabilities & Equity
198.6962.12114.9135.73108.18154.02
Total Debt
0.410.551.090.671.460.17
Net Cash (Debt)
191.758.5109.6829.299.71147.5
Net Cash Growth
227.68%-46.66%275.58%-70.71%-32.40%175.13%
Net Cash Per Share
14.124.3331.8211.9240.7081.30
Book Value
184.3556.18103.83-101.8499.97147.21
Book Value Per Share
13.584.1630.12-41.5740.8181.14
Tangible Book Value
184.3556.18103.83-101.8499.97147.21
Tangible Book Value Per Share
13.584.1630.12-41.5740.8181.14
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q